Search
AstraZeneca PLC
AZNAdd to Watchlist
189.390USD
+2.960+1.59%
Close 11-09 16:00（ET）
293.71BMarket Cap
28.22P/E TTM
After-hours 19:00 (ET)189.390USD+0.140+0.07%
After-hours 19:00 (ET)AstraZeneca PLC (AZN) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to AstraZeneca PLC in the past month.
Buy
5 Strong Buy
7 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
206.935USD+10.87%
AZN Analyst Recommendation Trends
In the current month, AZN has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AZN average Analyst price target in the last month is 206.935.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
5
5
5
5
5
4
3
1
7
7
6
6
6
6
4
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
12
11
11
10
7
2
AZN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Pfizer Inc
PFE
4
6
17
2
1
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, AZN EPS is projected to reach 2.414 in FY2026Q4, following reported EPS of 2.010 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
2.58
2.54
2.62
2.41
2.71
Actual
0.99
1.62
2.01
--
--
Surprise
-61.47%
-36.24%
-23.39%
--
--
FAQs
What is AstraZeneca PLC's expected revenue for the next quarter?
AstraZeneca PLC's expected revenue is 16.64B.
What is AstraZeneca PLC's price target?
Analysts forecast that AstraZeneca PLC's price target is USD 213.52, with the highest forecast at USD 258.72 and the lowest forecast at USD 158.00.
How have AstraZeneca PLCAZN's recent earnings per share performed?
The market expectation was USD 2.01, while AstraZeneca PLCAZN's earnings per share (EPS) for the previous quarter was USD 1.62. EPS for the next quarter is expected at USD 2.41.
What is the analyst rating for AstraZeneca PLC?
Based on the ratings of AstraZeneca PLC's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.